Dr Remi Tokunbo Okwechime, MD in Rochester, NY - Medicare Critical Care (intensivists)

Dr Remi Tokunbo Okwechime, MD is a medicare enrolled "Psychiatry & Neurology - Neurocritical Care" physician in Rochester, New York. She graduated from medical school in 2005 and has 19 years of diverse experience with area of expertise as Critical Care (intensivists). She is a member of the group practice Intensive Care Consortium Inc, U Of R Neurology Department, Auburn Community Hospital and her current practice location is 601 Elmwood Ave, Rochester, New York. You can reach out to her office (for appointments etc.) via phone at (585) 275-1200.

Dr Remi Tokunbo Okwechime is licensed to practice in New York (license number 311801) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033566849.

Contact Information

	Dr Remi Tokunbo Okwechime, MD
	601 Elmwood Ave, Rochester, NY 14642-6500
	(585) 275-1200
	Not Available

Physician's Profile

Full Name	Dr Remi Tokunbo Okwechime
Gender	Female
Speciality	Critical Care (intensivists)
Experience	19 Years
Location	601 Elmwood Ave, Rochester, New York
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Remi Tokunbo Okwechime graduated from medical school in 2005

NPI Data:

NPI Number: 1033566849
Provider Enumeration Date: 05/21/2016
Last Update Date: 10/30/2023

Medicare PECOS Information:

PECOS PAC ID: 8123356060
Enrollment ID: I20210729001591

Medical Identifiers

Medical identifiers for Dr Remi Tokunbo Okwechime such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033566849	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0200X	Internal Medicine - Critical Care Medicine	313222 (Louisiana)	Secondary
2084A2900X	Psychiatry & Neurology - Neurocritical Care	311801 (New York)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Marion Communtiy Hospital	Ocala, FL	Hospital
Auburn Community Hospital	Auburn, NY	Hospital
Strong Memorial Hospital	Rochester, NY	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Intensive Care Consortium Inc	0244269413	370
U Of R Neurology Department	1456248699	86
Auburn Community Hospital	2365346525	46

News Archive

Research studies may lead to future development of cell transplant therapy for ALS

The University of California, San Diego, The Salk Institute for Biological Studies and Life Technologies Corporation today announced the initiation of studies which may lead to the future development of cell transplant therapy for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. Currently, there is only one FDA-approved pharmaceutical addressing this lethal disease, which affects approximately 30,000 people in the United States.

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show.

Artificial intelligence can predict risk of premature death

Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.

Dell hedging on health IT investment; Privacy concerns remain

The Wall Street Journal: Dell is hoping to capitalize on its purchase of health technology firm Perot Systems by providing services to new clients such as the 2,600-doctor Methodist Hospital System in Houston. Dell has contracted to create an electronic medical records system for Methodist, a new foray into IT services for the hardware-focused firm.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Remi Tokunbo Okwechime allows following entities to bill medicare on her behalf.

Entity Name	Intensive Care Consortium Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1629019062 PECOS PAC ID: 0244269413 Enrollment ID: O20050808000883

News Archive

Research studies may lead to future development of cell transplant therapy for ALS

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Artificial intelligence can predict risk of premature death

Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.

Dell hedging on health IT investment; Privacy concerns remain

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Remi Tokunbo Okwechime is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Remi Tokunbo Okwechime, MD Elmwood Ave Box 278984, Rochester, NY 14642-0001 Ph: (585) 275-1200	Dr Remi Tokunbo Okwechime, MD 601 Elmwood Ave, Rochester, NY 14642-6500 Ph: (585) 275-1200

News Archive

Research studies may lead to future development of cell transplant therapy for ALS

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Artificial intelligence can predict risk of premature death

Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.

Dell hedging on health IT investment; Privacy concerns remain

Psychiatry & Neurology Doctors in Rochester, NY

Kevin Paul Brazill, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2613 W Henrietta Rd, Rochester, NY 14623 Phone: 585-279-4999
Jason Don Crowley, M.D., M.P.H. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Pinewild Dr Ste A2, Rochester, NY 14606 Phone: 585-368-6700
Sanjay Kevin Anandaram, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 445, Rochester, NY 14621 Phone: 585-922-4371 Fax: 585-922-7485
Cameron Elizabeth Houle, FNP-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 919 Westfall Rd Ste 100, Rochester, NY 14618 Phone: 585-341-7500
Dr. Wendy Rosen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11 North Goodman St. Room #24, Rochester, NY 14607 Phone: 585-473-8180 Fax: 585-473-8180
Dr. Julie L Fudge, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 370 Westminster Rd, Rochester, NY 14607 Phone: 585-241-3648
Irene H Richard, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 919 Westfall Rd, Bldg C, Suite 220, Rochester, NY 14618 Phone: 585-341-7500 Fax: 585-341-7510

Dr Remi Tokunbo Okwechime, MD - Medicare Critical Care (intensivists) in Rochester, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Research studies may lead to future development of cell transplant therapy for ALS

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Artificial intelligence can predict risk of premature death

Dell hedging on health IT investment; Privacy concerns remain

Medicare Reassignments

Research studies may lead to future development of cell transplant therapy for ALS

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Artificial intelligence can predict risk of premature death

Dell hedging on health IT investment; Privacy concerns remain

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Research studies may lead to future development of cell transplant therapy for ALS

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Artificial intelligence can predict risk of premature death

Dell hedging on health IT investment; Privacy concerns remain

Psychiatry & Neurology Doctors in Rochester, NY